This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
On Christmas Day, Elon Musk turned heads with a decadent photo by his tree. Dressed head-to-toe in a Santa costume, he ...
Elon Musk, the richest man in the world and self-described ‘First Buddy’, on Wednesday signalled his support for weight loss ...
Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...
The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...
More than half a million people are buying weight-loss injections online because of the “slow” rollout of the drugs by the ...
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...
Two of the leading experts on anti-obesity drugs say the drugs are heralding a new era in medicine and could soon be used to treat a raft of other conditions. David Ricks, the chair and chief ...
On Tuesday, November 26, the Centers for Medicare and Medicaid Services (CMS) proposed a new statutory interpretation that, if finalized, would result in expanded Medicare and Medicaid coverage for ...